Advertisement
Screener

Mirum Pharmaceuticals, Inc. (MIRM) Net Margin

Mirum Pharmaceuticals, Inc. (MIRM) Net Margin

  • 2026-06-30: Net Margin -38.14%.
  • 2026-03-31: Net Margin -494.21%.
  • 2025-12-31: Net Margin -3.85%.
  • 2025-09-30: Net Margin 2.18%.

Complete source-backed net margin history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-38.14%
2026-03-31-494.21%
2025-12-31-3.85%
2025-09-302.18%
2025-06-30-4.59%
2025-03-31-13.15%
2024-12-31-23.93%
2024-09-30-15.75%
2024-06-30-31.64%
2024-03-31-36.52%
2023-12-31-51.27%
2023-09-30-49.42%
2023-06-30-197.45%
2023-03-31-95.35%
2022-12-31-130.55%
2022-09-30-190.13%
2022-06-30-153.98%
2022-03-31-283.94%
2021-12-311833.84%
2021-09-30-942.16%
2021-06-30-399.04%

Annual Net Margin

DateNet Margin
2025-12-31-4.48%
2024-12-31-26.10%
2023-12-31-87.68%
2022-12-31-176.05%
2021-12-31-438.85%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Liquidia Corp (LQDA)United States$6.347B51.23
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B